Preisvorträge

  • C. Bode
  • T. Nordt
  • M. Freitag
  • J. Ruef
  • M. Kaltenmeier
  • G. Meinhardt
  • W. Kübler
  • E. Haber
  • R. Klingel
  • S. Störkel
  • W. Dippold
  • H.-J. Rumpelt
  • H. Köhler
  • K.-H. Meyer zum Büschenfelde
  • H. Matthes
  • H. Herbst
  • D. Schuppan
  • A. Stallmach
  • S. Milani
  • H. Stein
  • E.-O. Riecken
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 97)

Zusammenfassung

Therapie mit Plasminogenaktivatoren führt zu einer signifikanten Reduktion der Mortalität bei Patienten mit akutem Myokardinfarkt. Trotzdem verbleibt eine Reihe von Problemen, die durch bessere Plasminogenaktivatoren überwunden werden könnten. In etwa 25% aller behandelten Patienten sind die derzeit verfügbaren Plasminogenaktivatoren nicht ausreichend wirksam, da eine Reperfusion entweder nicht oder zu spät erreicht wird. Darüberhinaus limitiert eine hohe Rate früher Reverschlüsse den Therapieerfolg.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bode C, Meinhardt G, Runge M, Freitag M, Nordt T, Arens M, Newell JB, Kübler W, Haber E (1991) Platelet-targeted fibrinolysis enhances clot lysis and inhibits platelet aggregation. Circulation (in press)Google Scholar
  2. 2.
    Bode C, Kübler W (1989) Antikörper-vermittelte Thrombolyse. Ein neues therapeutisches Prinzip. Klin Wochenschrift 67: 651-658Google Scholar
  3. 3.
    Bode C, Runge M, Schönermark S, Eberle T, Newell JB, Kübler W, Haber E (1990) Conjugation to an antifibrin Fab' enhances the fibrinolytic potency of single-chain urokinase plasminogen activator. Circulation 81: 1974 - 1980PubMedCrossRefGoogle Scholar
  4. Bernstein J, Evan AP, Gardner KD (1987) Epithelial hyperplasia in human polycystic kidney disease — its role in pathogenesis and risk of neoplasia. Am J Pathol 129: 92 - 101PubMedGoogle Scholar
  5. Breuning MH, Reeders ST, Brunner H, Ijdo JW, Saris JW, Verwest A, van Ommen GJB, Pearson PL (1987) Improved early diagnosis of adult polycystic kidney disease with flanking DNA markers. Lancet II: 1359 - 1361Google Scholar
  6. Breuning MH, Snijdewint FGM, Brunner H, Verwest A, Ijdo JW, Saris JJ, Dauwerse JG, Blonden L, Keith T, Callen DF, Hyland VJ, Xiao GH, Scherer G, Higgs DR, Harris P, Bachner L, Reeders ST, Germinio G, Pearson PL, van Ommen GJB (1990) Map of 16 polymorphic loci on the short arm of chromosome 16 close to the polycystic kidney disease gene (PKD1). J Med Genet 27: 603 - 613PubMedCrossRefGoogle Scholar
  7. Churchill DN, Bear JC, Morgan J, Payne RH, McMannamon Pi, Gault MH (1984) Prognosis of adult onset polycystic kidney disease reevaluated. Kidney Int 26: 190 - 193PubMedCrossRefGoogle Scholar
  8. Cowley BD, Smardo FL, Grantham JJ, Calvet JP (1987) Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease. Proc Natl Acad Sci USA 84: 8394 - 8398PubMedCrossRefGoogle Scholar
  9. Cowley BD, Chadwick LJ, Grantham JJ, Calvet JP (1989) Sequential protooncogene expression in regenerating kidney following acute renal injury. J Biol Chem 264: 8389 - 8393PubMedGoogle Scholar
  10. Dippold WG, Bernhard H, Klingel R, Dienes HP, Kron G, Schneider B, Knuth A, Meyer zum Büschenfelde K-H (1987a) A common epithelial cell surface antigen (EPM-1) on gastrointestinal tumors and in human sera. Cancer Res 47: 3873 - 3879PubMedGoogle Scholar
  11. Dippold WG, Klingel R, Bernhard H, Dienes HP, Knuth A, Meyer zum Büschenfelde K-H (1987 b) Secretory epithelial cell marker on gastrointestinal tumors and in human secretions defined by a monoclonal antibody. Cancer Res 47: 2092 - 2097Google Scholar
  12. Ebihara I, Killen PD, Laurie GW, Huang T, Yamada Y, Martin GR, Brown KS (1988) Altered mRNA expression of basement membrane components in a murine model of polycystic kidney disease. Lab Invest 58: 262 - 269PubMedGoogle Scholar
  13. Evan AP, Gardner KD, Bernstein J (1979) Polypoid and papillary epithelial hyperplasia: a potential cause of ductal obstruction in adult polycystic disease. Kidney Int 16: 743750Google Scholar
  14. Faraggiana T, Bernstein J, Strauss L, Chirg J (1985) Use of lectins in the study of histogenesis of renal cysts. Lab Invest 53: 575 - 579PubMedGoogle Scholar
  15. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759 - 767PubMedCrossRefGoogle Scholar
  16. Gattone VH, Calvet JP, Cowley BD, Evan AP, Shaver TS, Helmstedter K, Grantham JJ (1988) Autosomal recessive polycystic kidney disease in a murine model: a gross and microscopic description. Lab Invest 59: 231 - 238PubMedGoogle Scholar
  17. Gattone VH, Andrews GK, Niu FW, Chadwick LJ, Klein RM, Calvet JP (1990) Defective epidermal growth factor gene expression in mice with polycystic kidney disease. Dev Biol 138: 225 - 230PubMedCrossRefGoogle Scholar
  18. Granot Y, van Putten V, Przekwas J, Gabow PA, Schrier RW (1990) Intra-and extracellular proteins in human normal and polycystic kidney epithelial cells. Kidney Int 37: 1301 - 1309PubMedCrossRefGoogle Scholar
  19. Grantham JJ (1990) Polycystic kidney disease: neoplasia in disguise. Am J Kidney Dis 25: 110 - 116Google Scholar
  20. Grantham JJ, Geiser JL, Evan AP (1987) Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 31: 1145 - 1152PubMedCrossRefGoogle Scholar
  21. Horikoshi S, Kubota S, Martin GR, Yamada Y, Klotman PE (1991) Epidermal growth factor ( EGF) expression in the congenital polycystic mouse kidney. Kidney Int 39: 57-62Google Scholar
  22. Ishikawa I, Saito Y, Shikura N, Kitada H, Shinoda A, Suzuki S (1990) Ten-year prospective study on the development of renal cell carcinoma in dialysis patients. Am J Kidney Dis 16: 452 - 458PubMedGoogle Scholar
  23. Kartha S, Bradham DM, Grotendorst GR, Toback FG (1988) Kidney epithelial cells express c-sis protooncogene and secrete PDGF-like protein. Am J Physiol 255: F800 — F806PubMedGoogle Scholar
  24. Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujanski E, Gabow PA (1988) Linkage heterogeneity of autosomal dominant polycystic kidney disease. New Engl J Med 319: 913 - 917PubMedCrossRefGoogle Scholar
  25. Klingel R, Boukamp P, Moll R, Tilgen W, Fusenig NE, Meyer zum Büschenfelde K-H, Dippold WG Expression of epithelial antigens Exo-1 and EPM-1 in human epidermal keratinocyte maturation and benign and malignant neoplasia. Cancer Res 50: 7668 - 7676Google Scholar
  26. Klingel R, Dippold W, Meyer zum Büschenfelde K-H (1991) Schleimhaut-Polyp-KarzinomGoogle Scholar
  27. Ein molekulargenetisches Modell der Entwicklung kolorektaler Tumoren. Dtsch med Wschr (im Druck)Google Scholar
  28. Lathrop GM, Lalouel JM (1984) Easy calculations of Iod scores and genetic risks on small computers. Am J Hum Genet 29: 235 - 239Google Scholar
  29. McAteer JA, Carone FA, Grantham JJ, Kempson SA, Gardner KD, Evan AP (1988) Explant culture of human polycystic kidney. Lab Invest 59: 126 - 136PubMedGoogle Scholar
  30. Moses HL, Yang EY, Pietenpol JA (1990) TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245 - 247PubMedCrossRefGoogle Scholar
  31. Norby S, Schwartz M (1990) Possible Locus for polycystic kidney disease on chromosome 2. Lancet I1: 323 - 324CrossRefGoogle Scholar
  32. Pardee AB (1989) G1 events and regulation of cell proliferation. Science 246: 603 - 608PubMedCrossRefGoogle Scholar
  33. Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Munger K, Howley PM, Moses HL (1990) TGF-betal inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777 - 785PubMedCrossRefGoogle Scholar
  34. Preminger GM, Koch WF, Fried FA, McFarland E, Murphy E, Mandell J (1982) Murine congenital polycystic kidney disease: a model for studying development of cystic disease. J Urol 127: 556 - 560PubMedGoogle Scholar
  35. Reeders ST, Breuning MH, Corney G, Jeremiah SJ, Meera Khan P, Davies KE, Hopkinson DA, Pearson PL, Weatherall DJ (1986) Two genetic markers closely linked to adult polycystic kidney disease on chromosome 16. Brit Med J 292: 851 - 853CrossRefGoogle Scholar
  36. Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ (1985) A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317: 542 - 544PubMedCrossRefGoogle Scholar
  37. Romeo G, Devoto M, Costa G, Roncuzzi L, Catizone L, Zuchelli P, Germinio GG, Keith T, Weatherall DJ, Reeders ST (1988) A second genetic locus for autosomal dominant polycystic kidney disease. Lancet 1I: 8 - 10CrossRefGoogle Scholar
  38. Taub M, Laurie GW, Martin GR, Kleinman HK (1990a) Altered basement membrane protein biosynthesis by primary cultures of cpk/cpk mouse kidney. Kidney Int 37: 1090 - 1097PubMedCrossRefGoogle Scholar
  39. Taub M, Wang Y, Szczesny TM, Kleinman HK (1990b) Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultures in serum-free medium. Proc Natl Acad Sci USA 87: 4002 - 4006PubMedCrossRefGoogle Scholar
  40. Vehaskari VM, Hering-Smith KS, Moskowitz DW, Weiner ID, Hamm LL (1989) Effect of epidermal growth factor on sodium transport in the cortical collecting tubule. Am J Physiol 256: F803 — F809PubMedGoogle Scholar
  41. Wilson PD, Schrier RW, Breckon RD, Gabow PA (1986) A new method for studying human polycystic kidney disease epithelia in culture. Kidney Int 30: 371 - 378PubMedCrossRefGoogle Scholar
  42. Wilson PD, Sherwood AC (1991) Tubulocystic epithelium. Kidney Int 39: 450 - 463PubMedCrossRefGoogle Scholar
  43. 1.
    Bouchier I, Allan R, Hodgson H, Keigley M (1984) Textbook of Gastroenterology, Baillière Tindal. Chapter 12; pp 885 - 1007Google Scholar
  44. 2.
    Milani S, Herbst H, Schuppan D, Kim K, Riecken E, Stein H (1990) Gastroenterology 98: 175 - 184PubMedGoogle Scholar
  45. 3.
    Graham MF, Diegelmann RF, Elson CO, Lindblad WJ, Gotschalk N, Gay S, Gay R (1988) Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 94: 257 - 265PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • C. Bode
    • 1
  • T. Nordt
    • 1
  • M. Freitag
    • 1
  • J. Ruef
    • 1
  • M. Kaltenmeier
    • 1
  • G. Meinhardt
    • 1
  • W. Kübler
    • 1
  • E. Haber
    • 2
  • R. Klingel
    • 3
  • S. Störkel
    • 4
  • W. Dippold
    • 3
  • H.-J. Rumpelt
    • 4
  • H. Köhler
    • 3
  • K.-H. Meyer zum Büschenfelde
    • 3
  • H. Matthes
    • 5
  • H. Herbst
    • 6
  • D. Schuppan
    • 5
  • A. Stallmach
    • 5
  • S. Milani
    • 5
  • H. Stein
    • 6
  • E.-O. Riecken
    • 5
  1. 1.Medizinische Klinik IIIKardiologie der Universität HeidelbergUSA
  2. 2.Squibb Institute for Medical ResearchPrincetonUSA
  3. 3.I. Medizinische Klinik und PoliklinikDeutschland
  4. 4.lnstitut für PathologieUniversität MainzDeutschland
  5. 5.Abteilung für GastroenterologieDeutschland
  6. 6.Institut für Pathologie, Klinikum SteglitzFreien Universität BerlinDeutschland

Personalised recommendations